Clinical trial
Haploid Allogeneic Transplant Using the CliniMACS System
NCT00185679 · Ginna Laport, Other · Terminated
Key facts
| NCT number | NCT00185679 |
|---|---|
| Title | Haploid Allogeneic Transplant Using the CliniMACS System |
| Official title | A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies |
| Lead sponsor | Ginna Laport, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors, Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase, Myelodysplastic Syndrome (MDS) - High and Intermediate Risk, Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL) - Refractory |
| Intervention type | Device |
| Interventions | CliniMACS System |
| Enrollment | 13 |
| Start date | Nov 1, 2001 |
| Primary completion | Oct 1, 2009 |
| Completion | Feb 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 9, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: